Can Skin Bacteria Treat Atopic Dermatitis?

Trial Objectives

Many varieties of bacteria live naturally on human skin. Researchers in the national TIME-2 study want to find out if one of these bacteria, called Staphylococcus hominis or S. hominis, can safely and effectively help reduce symptoms of atopic dermatitis (eczema).

Volunteers in this study will be randomly assigned to receive either a gel containing S. hominis or a placebo (a medication containing no active ingredient).  Study participants will receive both the assigned gel or placebo treatment and a corticosteroid topically for two weeks, followed by 12 weeks of treatment without the corticosteroid. Swab samples will be collected from participants’ skin during clinic visits. They also will be monitored for changes in symptoms and side effects.